ArticleRespirology (Carlton, Vic.)2020
Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease - Reply.
Haruki KobayashiPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it